The daily coronavirus news roundup – friday, march 20th

Advancements in the search for a COVID-19 treatment, a description of the nasal swab test, and other fresh updates.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our daily “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for today, March 20, 2020.

1. Chloroquine May Fight Covid-19 — and Silicon Valley’s Into It

The U.S. Food and Drug Administration is officially going to begin testing anti-malaria drug chloroquine as a treatment for the coronavirus. This article by Wired digs deep into the role Silicon Valley entrepreneurs played in making that happen.

2. An Epidemic of False Confidence Related to COVID-19

Could coronavirus be a “fast and stealthy” disease that many people have already gotten and recovered from? Scientist and inventor Danny Hillis explores what we need to know to reasonably predict how the COVID-19 pandemic will play out — and how serologic testing is critical to that understanding.

3. Total Cost of Her COVID-19 Treatment: $34,927.43

A newly published TIME article recounts one woman’s experience navigating the U.S. healthcare system on her path to a COVID-19 diagnosis — and the massive bill that welcomed her at the end of it. The article includes advice from experts on how others can avoid sharing her financial fate.

4. Coronavirus Test: What Is It Like to Get the Nasal Swab for Detecting COVID-19?

Coronavirus test kits might currently be in short supply in the U.S., but as more become available, your chances of submitting to a COVID-19 screening are going to increase — this piece from TODAY let’s you know what to expect from the experience.

Meth addiction treatments are finally on the horizon
New antibody and drug therapies may soon help treat meth patients, who currently have no pharmacological interventions.
Blood test can find dozens of types of cancer, with few false positives
Grail’s Galleri multi-cancer blood test found multiple cancers in a study of over 6,000 patients.
ARPA-H: High-risk, high-reward health research is the mandate of new, billion-dollar US agency 
A new multibillion-dollar federal agency was created with a goal of supporting “the next generation of moonshots for health.”
Long COVID: Self-targeted immune attacks may lurk behind it
Researchers are working to get a more complete understanding of the cells and antibodies behind long COVID.
San Francisco decriminalizes plant-based psychedelics 
San Francisco joins Oakland, Santa Cruz, DC, and Denver in decriminalizing some psychedelics.
Up Next
Subscribe to Freethink for more great stories